| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.83.10.969 |
| P698 | PubMed publication ID | 9815144 |
| P2093 | author name string | Xu X | |
| Bernstein RD | |||
| Hintze TH | |||
| Recchia FA | |||
| McConnell PI | |||
| Vogel TR | |||
| P433 | issue | 10 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 969-979 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. | |
| P478 | volume | 83 |
| Q37872742 | AMP-activated protein kinase modulators: a patent review (2006 - 2010). |
| Q36616554 | AMP-activated protein kinase: Role in metabolism and therapeutic implications |
| Q47215993 | Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure. |
| Q35090369 | Acute and chronic endothelial dysfunction: implications for the development of heart failure |
| Q38162217 | Adrenoreceptors and nitric oxide in the cardiovascular system |
| Q45277560 | Akt signaling pathway in pacing-induced heart failure |
| Q43160404 | Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction |
| Q54567679 | Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. |
| Q46114357 | Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure |
| Q34005572 | Animal models of dilated cardiomyopathy for translational research |
| Q28268244 | Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management |
| Q43799957 | Bioenergetics in cardiac hypertrophy: mitochondrial respiration as a pathological target of NO*. |
| Q35035923 | Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity |
| Q26853363 | Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction |
| Q34975841 | Cardiac failure in C5-deficient A/J mice after Candida albicans infection |
| Q38057699 | Cardiac metabolism in hypertrophy and heart failure: implications for therapy |
| Q46167724 | Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance |
| Q39360754 | Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells |
| Q44925672 | Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure). |
| Q35543414 | Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters |
| Q37835753 | Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies |
| Q44030243 | Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice |
| Q89123147 | Decreased contractility and altered responses to inotropic agents in myocytes from tachypacing-induced heart failure canines |
| Q46604612 | Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts |
| Q44877651 | Dynamic 123I-BMIPP single-photon emission computed tomography in patients with congestive heart failure: effect of angiotensin II type-1 receptor blockade |
| Q44264771 | Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression |
| Q61937241 | Efectos del óxido nítrico sobre la función cardíaca |
| Q36940489 | Effect of nitric oxide synthase inhibition on the exchange of glucose and fatty acids in human skeletal muscle |
| Q45261461 | Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. |
| Q57824312 | Emerging Roles of Vascular Endothelium in Metabolic Homeostasis |
| Q34961540 | Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice |
| Q43568352 | Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO. |
| Q34623667 | Energy metabolism in the normal and failing heart: potential for therapeutic interventions |
| Q33784459 | Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo |
| Q44802290 | Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts |
| Q44188619 | Fatty acids are important for the Frank-Starling mechanism and Gregg effect but not for catecholamine response in isolated rat hearts. |
| Q38171215 | Heart failure and loss of metabolic control |
| Q46415573 | Heart failure and statins--why do we need a clinical trial? |
| Q36540577 | Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. |
| Q38124176 | Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure |
| Q46962272 | Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy |
| Q45187187 | Increased superoxide production causes coronary endothelial dysfunction and depressed oxygen consumption in the failing heart |
| Q35877561 | Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice |
| Q35844633 | Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy |
| Q36934608 | Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy |
| Q73226891 | Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts |
| Q34471936 | Lipid metabolism in the heart--contribution of BMIPP to the diseased heart |
| Q37728311 | Living high training low induces physiological cardiac hypertrophy accompanied by down-regulation and redistribution of the renin-angiotensin system |
| Q34769220 | Longitudinal Evaluation of Fatty Acid Metabolism in Normal and Spontaneously Hypertensive Rat Hearts with Dynamic MicroSPECT Imaging |
| Q55341036 | Loss of Metabolic Flexibility in the Failing Heart. |
| Q92074661 | Magnetic resonance hyperpolarization imaging detects early myocardial dysfunction in a porcine model of right ventricular heart failure |
| Q43799960 | Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO. |
| Q37296154 | Metabolic modulation and cellular therapy of cardiac dysfunction and failure |
| Q38125159 | Metabolic remodeling in chronic heart failure |
| Q37849446 | Metabolic remodelling in human heart failure |
| Q39395331 | Metabolic remodelling in hypertrophied and failing myocardium: a review. |
| Q37293624 | Metabolic remodelling of the failing heart: beneficial or detrimental? |
| Q37374980 | Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. |
| Q28385915 | Mitochondria in heart failure |
| Q36070074 | Mitochondrial energy metabolism in heart failure: a question of balance |
| Q28085025 | Mitochondrial pyruvate transport: a historical perspective and future research directions |
| Q44735500 | Mitochondrial respiratory abnormalities in patients with end-stage congenital heart disease |
| Q44932395 | Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation |
| Q34901592 | Myocardial adaptation of energy metabolism to elevated preload depends on calcineurin activity : a proteomic approach |
| Q34963345 | Myocardial contractile effects of nitric oxide |
| Q37139948 | Myocardial fatty acid metabolism and cardiac performance in heart failure |
| Q73426593 | Negative NO3- difference in human coronary circulation with severe atherosclerotic stenosis |
| Q78372199 | Nitric oxide in heart failure: friend or foe |
| Q43988600 | Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction |
| Q35813373 | Nitric oxide's role in the heart: control of beating or breathing? |
| Q46858031 | Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure |
| Q35175535 | Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. |
| Q30494729 | PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation |
| Q33689461 | Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart |
| Q43418638 | Premature death and age-related cardiac dysfunction in male eNOS-knockout mice |
| Q37121936 | Preservation of NO production by statins in the treatment of heart failure |
| Q42959488 | Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure |
| Q41806964 | Reduced coronary vasodilator responses to amlodipine in pacing-induced heart failure in conscious dogs: role of nitric oxide |
| Q44524269 | Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs |
| Q43819540 | Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs |
| Q24300987 | Regulation of cardiovascular cellular processes by S-nitrosylation |
| Q34761571 | Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5 |
| Q35960066 | Remodeling of left circumflex coronary arterial tree in pacing-induced heart failure. |
| Q43800061 | Respiratory alkalosis does not alter NOx concentrations in human plasma and erythrocytes |
| Q37038911 | Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure |
| Q58853856 | Reversible pulmonary trunk banding: IX. G6PD activity of adult goat myocardium submitted to ventricular retraining |
| Q35090358 | Role of nitric oxide in the pathophysiology of heart failure |
| Q34623680 | Role of nitric oxide in the regulation of substrate metabolism in heart failure |
| Q55663138 | Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. |
| Q44547278 | Shift in metabolic substrate uptake by the heart during development of alloxan-induced diabetes |
| Q64377303 | Signalling mechanisms in contraction-mediated stimulation of intracellular NO production in cat ventricular myocytes |
| Q54481620 | Simultaneous exposure to nitric oxide inhibition and angiotensin II overload: is it a murine model of mitochondrial dysfunction in nonischemic heart failure? |
| Q43761027 | Simvastatin reverses impaired regulation of renal oxygen consumption in congestive heart failure |
| Q28658055 | Small and large animal models in cardiac contraction research: advantages and disadvantages |
| Q37264479 | Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. |
| Q42339384 | The Endothelial Nitric Oxide Synthase (NOS3-786T>C) Genetic Polymorphism in Chronic Heart Failure: Effects of Mutant -786C allele on Long-term Mortality. |
| Q34667665 | The nitric oxide pathway and oxidative stress in heart failure |
| Q35119525 | The relationship between structure and function: why does reshaping the left ventricle surgically not always result in functional improvement? |
| Q34222988 | The role of nitric oxide in the failing heart |
| Q43173383 | Transthoracic sensor for noninvasive assessment of left ventricular contractility: validation in a minipig model of chronic heart failure. |
| Q33890891 | Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors. |
| Q34786236 | Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition. |
| Q36014884 | Viable myocardium: how much is enough? |
Search more.